The Combination of Amlodipine and Atorvastatin for Treating Patients with Hypertension and Hyperlipemia
Shirong Chen
Abstract
Shirong Chen
Abstract
Objective:To investigate the therapeutic effect of the combination of atorvastatin and amlodipine in hypertensive patients with primary high lipids.Methods: 76 hypertensive patients with primary high lipids were divided into two groups randomly;39 patients in the test group were treated with amlodipine plus atorvastatin,and other patients in the control group were treated with amlodipine only;all patients were treated for 16 weeks of We measured blood pressure,blood-lipid,C-reactive protein(CRP) and left ventricular mass index(LVMI).Results: After 16 weeks of treatment,blood pressure and LVMI were reduced in both groups(p0.05),but the indicators in the test group were significantly lower than those in the control group(p0.05);Meanwhile,blood-lipid and CRP in the test group were lower than those in control group(p0.05),and the serum concentration of high-density lipoprotein cholesterol in the test group was higher(p0.05).Conclusion: The combination of amlodipine-atorvastatin remarkablely reduced the blood pressure and reversed left ventricular remodeling,compared with amlodipine therapy.The combination of amlodipine and atorvastatin could be a good choice of the treatment in hypertensive patients with hypercholesterolemia in the clinical setting.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the therapeutic effect of the combination of atorvastatin and amlodipine in hypertensive patients with primary high lipids.Methods: 76 hypertensive patients with primary high lipids were divided into two groups randomly;39 patients in the test group were treated with amlodipine plus atorvastatin,and other patients in the control group were treated with amlodipine only;all patients were treated for 16 weeks of We measured blood pressure,blood-lipid,C-reactive protein(CRP) and left ventricular mass index(LVMI).Results: After 16 weeks of treatment,blood pressure and LVMI were reduced in both groups(p0.05),but the indicators in the test group were significantly lower than those in the control group(p0.05);Meanwhile,blood-lipid and CRP in the test group were lower than those in control group(p0.05),and the serum concentration of high-density lipoprotein cholesterol in the test group was higher(p0.05).Conclusion: The combination of amlodipine-atorvastatin remarkablely reduced the blood pressure and reversed left ventricular remodeling,compared with amlodipine therapy.The combination of amlodipine and atorvastatin could be a good choice of the treatment in hypertensive patients with hypercholesterolemia in the clinical setting.
Key concepts: Amlodipine, Atorvastatin, Medicine, Blood pressure, Internal medicine, Blood lipids, Cardiology, Pharmacology